Comparative Pharmacology
Head-to-head clinical analysis: DERMA SMOOTHE FS versus PANDEL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DERMA SMOOTHE FS versus PANDEL.
DERMA-SMOOTHE/FS vs PANDEL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fluocinolone acetonide is a corticosteroid that binds to glucocorticoid receptors, modulating gene transcription to inhibit pro-inflammatory cytokines and reduce inflammation, vasodilation, and edema.
Pandel (hydrocortisone probutate) is a topical corticosteroid that acts by inducing phospholipase A2 inhibitory proteins, collectively called lipocortins. These proteins inhibit the release of arachidonic acid from membrane phospholipids, thereby reducing the synthesis of prostaglandins, leukotrienes, and other inflammatory mediators. This results in vasoconstriction, decreased edema, and suppression of the inflammatory and pruritic responses.
Apply topically as a thin film to affected areas twice daily. Maximum weekly dose should not exceed 60 g.
Topical: Apply a thin film to affected skin areas twice daily. Maximum: 15 g per application; not to exceed 60 g per week.
None Documented
None Documented
Terminal elimination half-life: 24-36 hours (systemic absorption after topical application); clinical context: prolonged with hepatic impairment.
2-4 hours (terminal); clinical context: requires frequent dosing due to rapid elimination.
Primarily renal (90%) as inactive metabolites; <5% unchanged. Biliary/fecal excretion accounts for <10%.
Primarily renal (90% as unchanged drug); biliary/fecal excretion negligible (<5%).
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid